|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China. |
| 公司地址
| 46, Avenue de la Great Army, Paris, FRA, 75017 |
| 電話號碼
| +33 153774000 |
| 傳真號碼
| +33 153774303 |
| 公司網頁
| https://www.sanofi.com |
| 員工數量
| 74846 |
| Ms. Madeleine Roach |
Executive Vice President, Business Operations |
-- |
17/02/2026 |
| Mr. Manuela Buxo |
Executive Vice President, Specialty Care |
-- |
17/02/2026 |
| Mr. Roy Papatheodorou |
Executive Vice President and General Counsel |
-- |
17/02/2026 |
| Mr. Brendan O'Callaghan |
Executive Vice President, Global Manufacturing and Supply |
-- |
17/02/2026 |
| Mr. Thomas Triomphe |
Executive Vice President, Vaccines |
-- |
17/02/2026 |
| Ms. Natalie Bickford |
Executive Vice President and Chief People Officer |
-- |
17/02/2026 |
| Mr. Houman Ashrafian |
Executive Vice President and Head of Research and Development |
-- |
17/02/2026 |
| Mr. Emmanuel Frenehard |
Executive Vice President and Chief Digital Officer |
-- |
17/02/2026 |
| Ms. Audrey Duval |
Executive Vice President, Corporate Affairs |
-- |
17/02/2026 |
| Mr. Francois-Xavier Roger |
Executive Vice President and Chief Financial Officer |
-- |
17/02/2026 |
| Mr. Olivier Charmeil |
Executive Vice President, General Medicines and Interim Chief Executive Officer |
-- |
17/02/2026 |
|
|
| Mr. Emile Voest |
Independent Director |
17/02/2026 |
| Ms. Barbara Lavernos |
Director |
17/02/2026 |
| Mr. Humberto De Sousa |
Director |
17/02/2026 |
| Mr. Wolfgang Laux |
Director |
17/02/2026 |
| Mr. Jean-Paul Kress, M.D. |
Independent Director |
17/02/2026 |
| Ms. Rachel Duan |
Independent Director |
17/02/2026 |
| Mr. John Sundy |
Independent Director |
17/02/2026 |
| Ms. Carole Ferrand |
Independent Director |
17/02/2026 |
| Mr. Christophe Babule |
Director |
17/02/2026 |
| Ms. Anne-Francoise Nesmes |
Independent Director |
17/02/2026 |
| Mr. Patrick Kron |
Independent Director |
17/02/2026 |
| Dr. Antoine Yver, M.D.,M.Sc. |
Independent Director |
17/02/2026 |
| Ms. Clotilde Delbos |
Independent Director |
17/02/2026 |
| Mr. Paul Hudson |
Director |
17/02/2026 |
| Mr. Frederic Oudea |
Chairman of the Board |
17/02/2026 |
| Ms. Lise Kingo |
Independent Director |
17/02/2026 |
|
|
|
|
